Gheidari F, Bakhshandeh B, Teimoori-Toolabi L, Mehrtash A, Ghadir M, Zeinali S. TCF4 silencing sensitizes the colon cancer cell line to oxaliplatin as a common chemotherapeutic drug. Anticancer Drugs. 2014 Sep;25(8):908–16. doi: 10.1097/cad.0000000000000118. PMID: 24869759.